An Update on the Use of Immunotherapy in the Treatment of Lymphoma

AbstractPurpose of ReviewThroughout the field of oncology, immunotherapy is moving further towards the first-line setting, and there is encouraging data for the use of these novel therapies in the management of lymphomas, utilizing treatments approved for both solid and hematologic malignancies. Herein, we review promising advances in this rapidly moving field from the past year.Recent FindingsIn the last year, we have seen promising clinical data on engineered antibody therapies for the treatment of lymphomas, as well as further optimization of engineered antibody fragments fused onto linkers or chimeric T cell receptors, both of the modalities capable of transforming non-specific T cells into tumor-specific, serial killer cells.SummaryHere we will review the promising data on these advan...

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2eDfGdA
via IFTTT